March 17, 2021
ECRI Publishes Top Patient Safety Issues for 2021
ECRI’s 2021 list of patient safety concerns can help health systems effectively identify, prioritize and respond to patient safety threats.
Tag: medications
March 17, 2021
ECRI’s 2021 list of patient safety concerns can help health systems effectively identify, prioritize and respond to patient safety threats.
March 15, 2021
Patient noncompliance is one of the most difficult challenges for healthcare providers. Noncompliance may include missed appointments and the failure to follow a plan of care, take medications as prescribed, or obtain recommended tests or consultations. Review this Risk Management Tip from MLMIC to reinforce related policies and protocols within your practice or facility.
March 10, 2021
Experts say patient-centric opioid intervention before discharge from the hospital can cut overall opioid intake, while still ensuring a patient is satisfied and their pain is properly managed.
March 3, 2021
The U.S. Food and Drug Administration issued an emergency use authorization for simultaneous administration of monoclonal antibodies bamlanivimab and etesevimab to treat COVID-19 patients who meet specific criteria.
March 2, 2021
ISMP says common medication mishaps can be prevented with proper attention and prioritization that results in system and practice changes.
February 9, 2021
The Emergency Care Research Institute’s 2021 list of technology hazards can help healthcare facilities effectively manage risks involving the use of medical devices and systems.
February 3, 2021
Medication stewardship programs are important efforts by all frontline healthcare workers and are becoming more common in dental practices, as well. In dental practices, dentists should exercise particular caution when prescribing antibiotics and opioids.
December 1, 2020
The Joint Commission’s seven patient safety goals it says should be the prioritized by hospitals in the coming year.
December 1, 2020
Patient nonadherence to a prescribed medication regimen is a common problem that physicians in all specialties encounter. Review this Risk Management Tip from MLMIC to reinforce related policies and protocols within your practice or facility.
November 11, 2020
The U.S. Food and Drug Administration has granted Eli Lilly and Company an emergency use authorization for bamlanivimab to treat mild-to-moderate COVID-19 in adult and pediatric patients.